A European multicentre drug utilisation study of the impact of regulatory measures on prescribing of codeine for pain in children

PURPOSE: In June 2013, following recommendations from the World Health Organization (WHO) and Food and Drug Administration (FDA), the European Medicines Agency agreed updates to the codeine product information regarding use for pain in children younger than 12 years and children undergoing tonsillec...

Descripción completa

Detalles Bibliográficos
Autores principales: Hedenmalm, Karin, Blake, Kevin, Donegan, Katherine, Macia, Miguel‐Angel, Gil, Miguel, Williams, Julie, Montero, Dolores, Candore, Gianmario, Morales, Daniel, Kurz, Xavier, Arlett, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771637/
https://www.ncbi.nlm.nih.gov/pubmed/31219227
http://dx.doi.org/10.1002/pds.4836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771637/
https://www.ncbi.nlm.nih.gov/pubmed/31219227
http://dx.doi.org/10.1002/pds.4836

Ejemplares similares